Report cards › Companies › Regeneron Pharmaceuticals
Regeneron Pharmaceuticals: Political money and lobbying (shown, not graded) records
Political money and lobbying (shown, not graded): 111 records from the U.S. Senate Office of Public Records (LDA.gov), from 2021 to 2026; 92 of them list an amount, $14,490,000 in all. Political money and lobbying (shown, not graded): 3 records from the Federal Election Commission, from 2022 to 2026; the amounts total $587,500. Outcomes as recorded: $251,000.00 to federal candidates' committees (2025-2026) (1), $175,500.00 to federal candidates' committees (2023-2024) (1), $161,000.00 to federal candidates' committees (2021-2022) (1).
Newest first; records 1 to 50 of 114. Each links to the agency's own record. Back to the report card.
| Date | Agency | What the agency recorded | Amount or outcome | Record | Retrieved | Matched | Report |
|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: BGR GOVERNMENT AFFAIRS reported $90,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2026 (3rd Quarter - Report); issues HCR | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $590,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 3rd Quarter (July 1 - Sep 30) of 2026 (3rd Quarter - Report); issues CPT, HCR, MMM, TAX, TRD | $590,000 · $590,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 19, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported $10,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2026 (3rd Quarter - Report); issues HCR | $10,000 · $10,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 16, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CHECKMATE GOVERNMENT RELATIONS reported $90,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS INC. in the 3rd Quarter (July 1 - Sep 30) of 2026 (3rd Quarter - Report); issues HCR | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 15, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: THE WASHINGTON TAX & PUBLIC POLICY GROUP reported $30,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2026 (3rd Quarter - Report); issues TAX | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 14, 2026 | Federal Election Commission | FEC: REGENERON PHARMACEUTICALS, INC. PAC (committee C00562264; connected organization REGENERON PHARMACEUTICALS, INC.) reported $251,000.00 in contributions to federal candidates' committees in the 2025-2026 cycle, reports through 2026-10-14 | $251,000 · $251,000.00 to federal candidates' committees (2025-2026) | Source record | Oct 24, 2026 | matched by name | Report an error |
| Aug 3, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2026 (2nd Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $630,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 2nd Quarter (Apr 1 - June 30) of 2026 (2nd Quarter - Report); issues CPT, HCR, MMM, TAX, TRD | $630,000 · $630,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: BGR GOVERNMENT AFFAIRS reported $90,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2026 (2nd Quarter - Report); issues HCR | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2026 (2nd Quarter - Report); issues HCR | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 15, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CHECKMATE GOVERNMENT RELATIONS reported $90,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS INC. in the 2nd Quarter (Apr 1 - June 30) of 2026 (2nd Quarter - Report); issues HCR | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 8, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: THE WASHINGTON TAX & PUBLIC POLICY GROUP reported $30,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2026 (2nd Quarter - Report); issues TAX | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| May 4, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2026 (1st Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2026 (1st Quarter - Report); issues BUD, HCR | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $640,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 1st Quarter (Jan 1 - Mar 31) of 2026 (1st Quarter - Report); issues CPT, HCR, MMM, TAX, TRD | $640,000 · $640,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: BGR GOVERNMENT AFFAIRS reported $90,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2026 (1st Quarter - Report); issues HCR | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 15, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CHECKMATE GOVERNMENT RELATIONS reported $90,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS INC. in the 1st Quarter (Jan 1 - Mar 31) of 2026 (1st Quarter - Report); issues HCR | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 1, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: THE WASHINGTON TAX & PUBLIC POLICY GROUP reported $30,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2026 (1st Quarter - Report); issues TAX | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 21, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2025 (4th Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $610,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 4th Quarter (Oct 1 - Dec 31) of 2025 (4th Quarter - Report); issues CPT, HCR, MMM, TAX, TRD | $610,000 · $610,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: BGR GOVERNMENT AFFAIRS reported $90,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2025 (4th Quarter - Report); issues HCR | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CHECKMATE GOVERNMENT RELATIONS reported $90,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS INC. in the 4th Quarter (Oct 1 - Dec 31) of 2025 (4th Quarter - Report); issues HCR | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 16, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: THE WASHINGTON TAX & PUBLIC POLICY GROUP reported $30,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2025 (4th Quarter - Report); issues TAX; bills named: H.R. 1990, S. 1649, H.R. 1 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 16, 2026 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2025 (4th Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: BGR GOVERNMENT AFFAIRS reported $90,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues HCR | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CHECKMATE GOVERNMENT RELATIONS reported $90,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS INC. in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues HCR | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $570,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues CPT, HCR, MMM, TAX, TRD | $570,000 · $570,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 16, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 14, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: THE WASHINGTON TAX & PUBLIC POLICY GROUP reported $30,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues TAX; bills named: H.R. 1990, S. 1649, H.R. 1 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 1, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2025 (3rd Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $610,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues CPT, HCR, MMM, TAX, TRD | $610,000 · $610,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: BGR GOVERNMENT AFFAIRS reported $90,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues HCR | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CHECKMATE GOVERNMENT RELATIONS reported $90,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS INC. in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues HCR | $90,000 · $90,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 17, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 11, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: THE WASHINGTON TAX & PUBLIC POLICY GROUP reported $30,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues TAX; bills named: H.R. 1990, S. 1649, H.R. 1 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 1, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2025 (2nd Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| May 5, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $400,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues CPT, HCR, MMM, TAX, TRD | $400,000 · $400,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CHECKMATE GOVERNMENT RELATIONS reported $30,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS INC. in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues HCR | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 17, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: THE WASHINGTON TAX & PUBLIC POLICY GROUP reported $30,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2025 (1st Quarter - Report); issues TAX; bills named: H.R. 1990 | $30,000 · $30,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report (No Activity)) | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 21, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $400,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report); issues CPT, HCR, MMM; bills named: H.R. 2670 | $400,000 · $400,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 17, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 7, 2025 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2024 (4th Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Dec 31, 2024 | Federal Election Commission | FEC: REGENERON PHARMACEUTICALS, INC. PAC (committee C00562264; connected organization REGENERON PHARMACEUTICALS, INC.) reported $175,500.00 in contributions to federal candidates' committees in the 2023-2024 cycle, reports through 2024-12-31 | $175,500 · $175,500.00 to federal candidates' committees (2023-2024) | Source record | Oct 24, 2026 | matched by name | Report an error |
| Oct 21, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $400,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 3rd Quarter (July 1 - Sep 30) of 2024 (3rd Quarter - Report); issues CPT, HCR, MMM; bills named: H.R. 2670 | $400,000 · $400,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 18, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2024 (3rd Quarter - Report (No Activity)) | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 17, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2024 (3rd Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 10, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2024 (3rd Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
CSWH is not affiliated with these agencies.